Overview

Intravenous Dexmedetomidine in Cesarean Section Under Spinal Anesthesia

Status:
Completed
Trial end date:
2019-11-19
Target enrollment:
Participant gender:
Summary
The present study hypothesized that intravenous dexmedetomidine use during spinal anesthesia for cesarean section has a beneficial influence on hemodynamic stability and epigastric pain together with satisfactory analgesic effects and excellent safety profile for the mother and the newborn.
Phase:
Phase 3
Details
Lead Sponsor:
Egyptian Biomedical Research Network
Treatments:
Dexmedetomidine